Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
December 2012
Features
Health Care & Law
Transitions of Care
Pitfalls and Recommendations
Medication errors, with methotrexate in particular, are all too common — especially when patients are moved from one site of care to another. The authors discuss ways to improve appropriate medication use during patient transitions.
James O’Donnell, PharmD, MS; and F. Randy Vogenberg, RPh, PhD
Management of Type-2 Diabetes Mellitus in Adults
Focus on Individualizing Non-Insulin Therapies
Successful management of hyperglycemia may involve glucose and non-glucose therapies, non-drug approaches, and non-insulin agents. Treatment should be tailored to each patient, with an emphasis on safety.
Luigi Brunetti, PharmD, MPH, BCPS, CGP; and Julie Kalabalik, PharmD, BCPS
Sitagliptin/Metformin (Janumet) as Combination Therapy In the Treatment of Type-2 Diabetes Mellitus
Used together, sitagliptin (Januvia) and metformin (Glucophage) help to improve glycemic levels in diabetic patients, suggesting a synergy between the agents.
However, the cost of sitagliptin and the need for more data may restrict its use. More studies are needed to assess the effects of long-term sitagliptin and to determine its role in combination therapy.
Erin L. St. Onge, PharmD; Shannon Miller, PharmD; and Elizabeth Clements, PharmD
Meeting Highlights
Transcatheter Cardiovascular Therapeutics 2012
Topics include comparisons of bivalirudin (Angiomax) and unfractionated heparin in reducing bleeding, prasugrel (Effient) and clopidogrel (Plavix) in acute myocardial infarction, aspirin for critical limb ischemia, and mobilized CD34+ cells for angina.
Walter Alexander
Thank You To Our 2012 Reviewers
Departments
Medication Errors
Avoiding Confusion With Alphanumeric Characters
Matthew Grissinger, RPh, FASCP
Prescription: Washington
‘Stage 2’ Incentive Rule for Electronic Records Highlights Importance of Hospital Pharmacy Data
Republicans Say Requirements for Incentives Are Set Too Low
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Marvin M. Goldenberg, PhD, RPh, MS
Drug Forecast
Vismodegib (Erivedge) For Advanced Basal Cell Carcinoma
Chris Fellner
